Reine Allan 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Aug 17, 2017
Insider Transaction Report
Form 4
Reine Allan
See Remarks
Transactions
- Purchase
Common Stock
2017-08-17$4.89/sh+20,000$97,800→ 65,000 total - Purchase
Common Stock
2017-08-16$4.79/sh+45,000$215,550→ 45,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.69 to $4.90, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.